Evidence map›Paper›PMID 25949211›Full record

ArticleSarcoma2015

Cured of primary bone cancer, but at what cost: a qualitative study of functional impairment and lost opportunities.

Lena Fauske, Oyvind S Bruland, Ellen Karine Grov, Hilde Bondevik

Open access · hybridAbstract read
In one paragraph

Article in Sarcoma, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 2 pooled it
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 2 syntheses or guidelines pooled it, 43 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Addressing and supporting the unmet needs of sarcoma survivors: a qualitative study.International journal of qualitative studies on health and well-being · 2025
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Mobility Assessment Instruments.Seminars in oncology nursing · 2024
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Development of a patient-reported experience questionnaire for patients with sarcoma: the Sarcoma Assessment Measure (SAM).Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2020
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Lena FauskeDepartment of Oncology, Oslo University Hospital, Norwegian Radium Hospital, P.O. Box 5960, Nydalen, 0424 Oslo, Norway.
Oyvind S BrulandDepartment of Oncology, Oslo University Hospital, Norwegian Radium Hospital, P.O. Box 5960, Nydalen, 0424 Oslo, Norway ; Institute of Clinical Medicine, University of Oslo, P.O. Box 1078, Blindern, 0316 Oslo, Norway.
Ellen Karine GrovFaculty of Health Sciences, Department of Nursing, Oslo and Akershus University College of Applied Sciences, St. Olavs plass, P.O. Box 4, 0130 Oslo, Norway.
Hilde BondevikInstitute of Health and Society, Department of Health Sciences, University of Oslo, P.O. Box 1089, Blindern, 0317 Oslo, Norway.
Oslo University Hospital · NOOsloMet – Oslo Metropolitan University · NOUniversity of Oslo · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose. Our study aims to explore how former cancer patients experience physical and psychosocial late effects 3-7 years after they underwent treatment for primary bone sarcoma in the hip/pelvic region. A qualitative, phenomenological, and hermeneutic design was applied. Methods. Sarcoma survivors (n = 10) previously treated at Oslo University Hospital, Norwegian Radium Hospital were selected to participate. In-depth and semistructured interviews were conducted. The interviews were analysed using inductive thematic analysis. Results. The participants reported that the late effects had three core spheres of impact: "their current daily life," "their future opportunities," and "their identity." They expressed negative changes in activity, increased dependence on others, and exclusion from participation in different areas. Their daily life, work, sports activities, and social life were all affected. Several of their experiences are similar to those described by people with functional impairment or disability. Conclusion. Patients cured of bone cancer in the hip/pelvic region pay a significant price in terms of functional impairment, practical challenges, exclusion from important aspects of life, and loss of previous identity. It is important to appreciate this in order to help bone cancer survivors who struggle to reorient their life and build a secure new identity.

Identifiers

PMID25949211
PMCPMC4407620
OpenAlexW1991660694

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.